Monday saw a spectacular increase in the share price of Artelo Biosciences, Inc. (NASDAQ: ARTL), which shot up 95.72% to close at $13.27. The dramatic increase followed positive findings from a first-in-human clinical trial assessing ART26.12, a potential treatment candidate with a distinct mode of
After a significant development update, shares of Citius Oncology, Inc. (NASDAQ: CTOR) jumped 20.50% to $1.88 as of the most recent check. LYMPHIR, an immunotherapy licensed by the FDA to treat relapsed or refractory cutaneous T-cell lymphoma (CTCL), is nearly ready for commercialization. The announcement
In the most recent trading session, United Homes Group, Inc. (NASDAQ: UHG) had a notable increase in share price, jumping 7.77% to $2.08. This rise carries on a robust five-day rally in which UHG’s stock price has risen 11.23%. Following a number of high-profile CEO
The stock of Cheche Group Inc. (NASDAQ: CCG) witnessed a notable increase on Thursday, ending trading at $1.03, up 9.57%. This rising trend has resulted in a gain of almost 3% during the previous five days. The anticipation around the company’s impending earnings release has
After the release of its fiscal third-quarter 2024 financial data, Mobix Labs, Inc. (NASDAQ: MOBX) stock saw a significant uptick on the charts. MOBX stock ended the day at $1.09 with a notable increase of 23.84% that highlighted a spike in investor confidence. Sturdy Financial
Sonder Holdings Inc. (NASDAQ: SOND) had an incredible increase in the value of its shares today, with the most recent check seeing a 91.74% increase to $5.03. This notable increase comes after Sonder announced the signing of a crucial license deal with Marriott International, Inc.,
On Friday, Oragenics, Inc. (NYSE: OGEN) received a significant boost in investor confidence following the regulatory approval for its lead drug candidate, ONP-002. This positive development propelled OGEN shares to a notable $1.40, marking a substantial increase of 29.63%. Successful Study Results for ONP-002 Oragenics
Imunon, Inc.’s (NASDAQ: IMNN) stock price has increased dramatically after the release of topline data from a critical clinical study. According to the most recent report, IMNN’s shares have increased 149.58% to $2.96. Good Results in the Second Phase of the OVATION Study Positive topline
After the announcement of a business combination deal, shares of TRxADE HEALTH, Inc. (NASDAQ: MEDS) have seen a significant increase on the US charts today. As of the latest weekend session check, MEDS stock had risen by 7.78% to reach $12.61. Closing of the Business
Shares of STRATA Skin Sciences, Inc. (NASDAQ: SSKN) experienced a notable increase on the stock market following promising peer-reviewed clinical trial results. After completing the previous session at $3.56, SSKN stock gained 13.02%; however, as of the most recent check made today, it was up
News IMC are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.
Allrights reserved ©2024, Powered by Smart TechOne